Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development
Search Refinements
Search Results: Drug Discovery & Development
1-15 of 5125 results
Through the Skin
Transdermal systems are pharmaceutical patches that transport the active substances directly into the bloodstream through the skin – often with fewer side effects than tablets.
Drug Research > Drug Discovery & Development > Press Releases
Indian firm develops two Zika vaccines
By PBR Staff Writer
Indian firm Bharat Biotech has unveiled two vaccine candidates to protect humans against the mosquito-borne Zika virus, which was recently been recognized as a global emergency by the World Health Organization.
Drug Research > Drug Discovery & Development > News
Cloud Pharmaceuticals completes 17 computational drug discovery projects
By PBR Staff Writer
Cloud Pharmaceuticals has completed 17 new computational drug discovery projects using its Quantum Molecular Design process to design molecules targeting a range of indications.
Drug Research > Drug Discovery & Development > News
UK cancer drug developer Mission Therapeutics raises £60m in funding round
By PBR Staff Writer
UK-based drug discovery and development firm Mission Therapeutics has raised £60m from investors and existing shareholders to advance its therapeutic programs.
Drug Research > Drug Discovery & Development > News
Sanofi launches project to develop vaccine for Zika virus
By PBR Staff Writer
French drugmaker Sanofi has launched a project to develop a vaccine against the mosquito-borne Zika virus, which is being spread rapidly in several regions globally.
Drug Research > Drug Discovery & Development > News
Allergan, AstraZeneca sign antibiotic development deal
By PBR Staff Writer
Allergan and AstraZeneca have signed a global agreement to develop and commercialize ATM-AVI, a fixed-dose antibiotic combining aztreonam and avibactam, to treat serious infections caused by metallo-β-lactamase-producing Gram-negative pathogens.
Drug Research > Drug Discovery & Development > News
EIB lends EUR20m to French biopharmaceutical firm Transgene
The European Investment Bank (EIB) and Transgene announced that they have entered into a EUR20m financing agreement.
Drug Research > Drug Discovery & Development > News
WHO warns Zika virus could affect four million people
By PBR Staff Writer
The World Health Organization (WHO) has said that the mosquito-borne Zika virus is spreading explosively and could affect three to four million people.
Drug Research > Drug Discovery & Development > News
Oxeia advances development of oxe-103 to treat concussions
Oxeia Biopharmaceuticals is catalyzing the development of first-in-class neurometabolic treatments for concussions and other aspects of brain injury.
Drug Research > Drug Discovery & Development > News
Optum, PAREXEL partner to reduce drug development costs related with post-approval studies
Optum and PAREXEL International have formed a strategic alliance to reduce drug development costs associated with post-approval studies, which are conducted after the approval of a product to obtain further evidence of its safety or effectiveness.
Drug Research > Drug Discovery & Development > News
Acorda Therapeutics to buy Biotie Therapies
By PBR Staff Writer
Biotechnology firm Acorda Therapeutics has agreed to acquire Finnish drug development company Biotie Therapies for about $363m.
Drug Research > Drug Discovery & Development > News
International consortium secures Eurostars grant to develop novel treatment for clotting disorders
A grant for €1.9m has been awarded under the Eurostars programme to a consortium that comprises Abzena's subsidiary Antitope, Dutch biopharmaceutical companies Prothix and Aristi Biotech, the University Medical Center Utrecht (UMCU, the Netherlands) and French firm GenOway.
Drug Research > Drug Discovery & Development > News
NeuroVive Pharmaceutical acquires minority stake in Isomerase Therapeutics
By PBR Staff Writer
NeuroVive Pharmaceutical has acquired a 5% stake in the UK-based drug discovery and development firm Isomerase Therapeutics.
Drug Research > Drug Discovery & Development > News
DelMar, MD Anderson partner to accelerate development of VAL-083 anti-cancer drug
By PBR Staff Writer
DelMar Pharmaceuticals has collaborated with the University of Texas MD Anderson Cancer Center to speed up the clinical development of its VAL-083 anti-cancer drug.
Drug Research > Drug Discovery & Development > News
Evotec achieves milestone in TargetAD collaboration with Janssen in Alzheimer's disease
Evotec announced the achievement of an important milestone in its TargetAD collaboration with Janssen Pharmaceuticals for the transition of a project into further drug discovery process.
Drug Research > Drug Discovery & Development > News

PBR Supplier Recommendations

Chemoswed - Suppliers of Active Pharmaceutical Ingredients
Chemoswed is the reliable Swedish custom synthesis specialist, supplying active ingredients since 1944. With a background in Pharmacia, Chemoswed is since 1996 an independent entity within the DuPont group, offering cost-effective, turn-key solutions to API needs worldwide.We have established unparalleled experience and technology, enabling efficient development and production of quality active pharmaceutical ingredients in quantities from 100 grams to 50 tons.... Drug Research > Drug Discovery & Development > Suppliers
Novo Nordisk Pharmatech A/S - Insulin Human and Benzalkonium Chloride Products
Novo Nordisk Pharmatech A/S is a Novo Nordisk company that specialises in the supply of ingredients for the biopharmaceutical and pharmaceutical industries, such as insulin human for cell culture media and cGMP manufactured quaternary ammonium compounds (usually referred to as quats) such as benzalkonium chloride, cetrimide and cetrimonium bromide.... Drug Research > Drug Discovery & Development > Suppliers
Biovian - cGMP Contract Manufacturing of Biopharmaceuticals
Biovian is a dynamic and effective new generation one-stop-shop CMO in cGMP contract manufacturing of biopharmaceuticals. Biovian's services cover the full range from antigen isolation, expression, vector construction, cell line cultivation, cGMP protein purification to product fill and finish.... Drug Research > Drug Discovery & Development > Suppliers
Tosoh Bioscience - Your Specialist in Separation
Tosoh Bioscience is an acknowledged global leader in the field of liquid chromatography with a strong focus on bioseparations. We offer solutions for research, drug discovery, clinical chemistry, environmental analysis, manufacturing and other industrial applications. ... Drug Research > Drug Discovery & Development > Suppliers
Lohmann Therapy System (LTS) - Transdermal Therapeutic Systems and Oral Thin Films
LTS is the market leader in alternative drug delivery systems, in the form of transdermal therapeutic systems and oral thin films. We develop and manufacture drug delivery systems that offer patients reliable therapeutic efficacy with total comfort and convenience.... Drug Research > Drug Discovery & Development > Suppliers
See more

PBR White Paper Recommendations

Sciences Radiolabelling Brochure By Almac
Trust Almac with your 14C radiolabelling requirements and we will offer advice on the most appropriate label position for your molecule, including synthetic feasibility and metabolic stability.... Drug Research > Drug Discovery & Development > White Papers Commerical Packaging By Almac
- Complementary US and UK operations, - Quality-driven, flexible packaging solutions, - Market leader for product launch of niche / orphan drug products, - Solid oral dose and biopharmaceutical packaging, - Packaging and artwork design, - Full serialisation and 2D matrix barcoding solutions.... Drug Research > Drug Discovery & Development > White Papers Providing an Unparalleled Range of Contract Pharmaceutical Development and Manufacturing Services Globally for Over 40 Years By Almac
Only we can combine the expertise from our range of specialised services to provide you with the right solutions to help you develop and commercialise your products.... Drug Research > Drug Discovery & Development > White Papers Building the Next Generation IRT: An Exclusive Look Under the Hood of IXRS®3 By Almac
Interactive Response Technology (IRT) systems - used to manage patient interactions and drug supplies during clinical trials - perform a range of functions for sponsors, drug depots, and investigative sites. Yet, they are typically viewed by sponsors as a "painful necessity" rather than as a welcome, invaluable tool. That perception exists because the underlying technology is outmoded, and the user's experience is stuck in the pre-Internet era. While established systems are "tried and true" in that they have supported thousands of clinical trials over the years, they can also be tired and cumbersome.... Drug Research > Drug Discovery & Development > White Papers Introducing Direct to Patient Shipments By Almac
Almac will ship the Clinical Trial Material (CTM) to participating clinical sites, where the drug is to be stored. Both shipping and storage of the CTM will follow standard procedures. Sites will interact with the Interactive Response Technology (IRT) provider in the usual way to obtain a kit assignment.... Drug Research > Drug Discovery & Development > White Papers See more
1-15 of 5125 results